Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Reviva Pharmaceuticals Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 24 | +1 |
| Shares | 2.65M | 2.66M | +18.3K (+0.7%) |
| Value | $15.5M | $13.0M | −$2.53M (−16.3%) |
New holders (5)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Group One Trading, L.P. | 129,301 | $631.0K | 0.03% |
| Sabby Management, LLC | 44,593 | $217.6K | 0.69% |
| Qube Research & Technologies Ltd | 3,026 | $14.8K | 0.00% |
| Cutler Group LP | 1,600 | $7.00K | 0.00% |
| Archer Investment Corp | 500 | $2.44K | 0.00% |
Sold out (4)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 35,300 | $207.0K |
| Virtu Financial LLC | 18,448 | $108.0K |
| Commonwealth Equity Services, LLC | 13,382 | $78.0K |
| Tower Research Capital LLC (TRC) | 11,109 | $65.1K |